Bottom Line
It's not a great sign when a company that has only been public for a month is already disclosing less information to investors.
Lyft's decision ... Read More»
Curaleaf (CNSX: CURA) reported strong 2018 numbers, clearly indicating they are set to dominate U.S. marijuana in 2019. Is the stock price is justified? ... Read More»
GW Pharmaceuticals (NASDAQ: GWPH) has been on a tear over the past month after exceeding expectations with its Q4 results, which were released at the end of Feb... Read More»
Nvidia Q4 2019 earnings showed dissapointing results but the market reacted favourably since company had already lowered expectations last month.... Read More»
Highlights
Earnings per share of $1.30 at a very healthy clip of 21% year-on-year for the quarter, topping analyst expectations of $1.25/share by 4%.
Re... Read More»
Bottom Line
The combination of hubris and declining transparency is never a good combination in a fledgling industry.
Canopy Growth stock (TSE: WEED) shoul... Read More»